Download PDF
Pneumologie 2008; 62(5): 255-272
DOI: 10.1055/s-2008-1038148
Leitlinie
© Georg Thieme Verlag Stuttgart · New York

Tabakentwöhnung bei COPD - S3 Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin

Guidelines for Smoking Cessation in Patients with COPD Issued by the Deutsche Gesellschaft für Pneumologie und BeatmungsmedizinS.  Andreas1 , A.  Batra2 , J.  Behr3 , H.  Berck4 , J.-F.  Chenot5 , A.  Gillissen6 , T.  Hering7 , F.  Herth1 , R.  Meierjürgen8 , S.  Mühlig9 , D.  Nowak1 , M.  Pfeifer1 , T.  Raupach1 , K.  Schultz1 , H.  Sitter10 , H.  Worth11
  • 1Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP)
  • 2Wissenschaftlicher Aktionskreis Tabakentwöhnung (WAT) e.V.
    Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN)
    Deutsche Gesellschaft für Suchtforschung und Suchttherapie (DG-Sucht) e.V.
  • 3Leitlinienkoordinator der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP)
  • 4Selbsthilfegruppe Patientenliga Atemwegserkrankungen e.V.
  • 5Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V. (DEGAM)
  • 6Deutsche Gesellschaft für Innere Medizin e.V. (DGIM)
  • 7Stellvertretender Vorsitzender des Bundesverbandes der Pneumologen (BDP)
  • 8Barmer Ersatzkasse
  • 9Vertreter der Fachgruppe „Klinische Psychologie” der Deutschen Gesellschaft für Psychologie e.V. (DGPs)
  • 10 Institut für Theoretische Chirurgie, Philipps-Universität Marburg
  • 11 Vorsitzender der Deutschen Atemwegsliga e.V.
Further Information

Publication History

Publication Date:
07 May 2008 (online)

Also available at
    Permissions and Reprints

Inhalt Seite 1. Einleitung 255 2. Evidenzdarlegung der Leitlinie Tabakentwöhnung bei COPD 256 3. Erstellungsprozess 256 4. Epidemiologie des Zigarettenrauchens 256 5. Tabakkonsum und Tabakabhängigkeit 256 6. Tabakrauchen verursacht eine Vielzahl von Lungenerkrankungen 257 7. Tabakrauchen als Ursache der COPD 258 8. Passivrauchen als Ursache der COPD 259 9. Tabakrauchen bei Patienten mit COPD 259 10. Anamnese 259 11. Diagnostik/Fragebogen 260 12. Motivierende Beratung 261 13. Effekte der Tabakentwöhnung 262 14. Rauchreduktion ist keine Alternative zum Rauchstopp 262 15. Integrierter Ansatz, Tabakentwöhnungsprogramm 263 16. Tabakentwöhnung in ambulanten und stationären Strukturen 263 17. Medikamentöse Behandlung 264 18. Prävention und gesundheitsökonomische Aspekte 265 19. Qualitätsindikatoren 266 20. Anhang 266 21. Literatur 267

Literatur

  • 1 Bloch R E, Lauterbach K, Oesingmann U. et al . Beurteilungskriterien für Leitlinien in der medizinischen Versorgung - Beschlüsse der Vorstände der Bundesärztekammer und Kassenärztlicher Bundesvereinigung, Juni 1997.  Deutsches Ärzteblatt. 1997;  94 A2154/B-1831/C-1635
    Google Scholar
  • 2 Phillips B, Ball C, Sackett D. Levels of evidence, http://www.cebm.net/index.aspx?o = 1025.  Oxford. Centre for Evidence-based Medicine 2001
    Google Scholar
  • 3 Abholz H H, Gillissen A, Magnussen H. et al .Nationale VersorgungsLeitlinie COPD, Langfassung, Version 1.2. In: Bundesärztekammer (BÄK) Arbeitsgemeinschaft der Deutschen Ärztekammern, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) 2006
    Google Scholar
  • 4 Forsyth L, Graham K, Harbour R T. et al .SIGN 50: A guideline developers' handbook. Edinburgh: Scottish Intercollegiate Guidlines Network 2004
    Google Scholar
  • 5 Bundesärztekammer (BÄK), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV) .Nationales Programm für Versorgungs-Leitlinien. Methoden-Report 2004
    Google Scholar
  • 6 Tonnesen P, Carrozzi L, Fagerstrom K O. et al . Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy.  Eur Respir J. 2007;  29 390-417
    Google Scholar
  • 7 Vogelmeier C, Buhl R, Criée C P. et al . Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin.  Pneumologie. 2007;  61 1-40
    Google Scholar
  • 8 Pauwels R A, Buist A S, Calverley P M. et al . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.  Am J Respir Crit Care Med. 2001;  163 1256-1276
    Google Scholar
  • 9 Rabe K F, Hurd S, Anzueto A. et al . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.  Am J Respir Crit Care Med. 2007;  176 532-555
    Google Scholar
  • 10 Aigner K, Homeier I, Koessler W. et al . Standards der Raucherentwöhnung, Konsensus der ÖGP.  Wiener Klinische Wochenschrift. 2005;  117 Supplement 2 1-22
    Google Scholar
  • 11 National Health Committee .Guidelines for Smoking Cessation.  Wellington, New Zealand 2004
    Google Scholar
  • 12 National Collaborating Centre for Chronic Conditions, (NICE) . Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.  Thorax. 2004;  59 1-232
    Google Scholar
  • 13 West R, McNeill A, Raw M. Smoking Cessation Guidelines for Scotland: 2004 Update. In: NHS Health Scotland and ASH Scotland 2004
    Google Scholar
  • 14 Batra A, Lindinger P, Schütz C. Tabakbedingte Störungen „Leitlinie Tabakentwöhnung”. In: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften 2004
    Google Scholar
  • 15 Anderson J E, Jorenby D E, Scott W J. et al . Treating Tobacco Use and Dependence: An Evidence-Based Clinical Practice Guideline for Tobacco Cessation.  Chest. 2002;  121 932-941
    Google Scholar
  • 16 Orsetti K. Smoking Cessation Guideline. In: University of Michigan Health System 2001
    Google Scholar
  • 17 Bundesärztekammer, Kassenärztliche Bundesvereinigung . Checkliste Methodische Qualität von Leitlinien, 2. Version (8/1999).  Deutsches Ärzteblatt. 2000;  97 A1170
    Google Scholar
  • 18 Parrott S, Godfrey C. Economics of smoking cessation.  Bmj. 2004;  328 947-949
    Google Scholar
  • 19 Fiore M C. Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline.  Respir Care. 2000;  45 1196-1199
    Google Scholar
  • 20 U.S. Department of Health and Human Services .Reducing Tobacco Use: A Report of the Surgeon General.  Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2000
    Google Scholar
  • 21 Rosser W, Tremblay M. Smoking Cessation Guidelines. In: Pegasus Healthcare International 2000
    Google Scholar
  • 22 West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority.  Thorax. 2000;  55 987-999
    Google Scholar
  • 23 Parrott S, Godfrey C, Raw M. et al . Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority.  Thorax. 1998;  53 Suppl 5 S1-38
    Google Scholar
  • 24 Raw M, McNeill A, West R. Smoking Cessation Guidelines for Health Professionals - A guide to effective smoking cessation interventions for the health care system.  Thorax. 1998;  53 1-18
    Google Scholar
  • 25 Arzneimittelkommission der deutschen Ärzteschaft . Empfehlungen zur Therapie der Tabakabhängigkeit.  Suchtmed. 2001;  3 156-175
    Google Scholar
  • 26 Hoch E, Mühlig S, Nowak D. et al .Rauchen und Nikotinabhängigkeit in Deutschland: Eine klinisch-epidemiologische Perspektive. Zeitschrift für klinische Psychologie und Psychotherapie (in press)
    Google Scholar
  • 27 Lampert T, Burger M. Verbreitung und Strukturen des Tabakkonsums in Deutschland.  Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2005;  48 1231-1241
    Google Scholar
  • 28 Janson C, Kunzli N, de Marco R. et al . Changes in active and passive smoking in the European Community Respiratory Health Survey.  Eur Respir J. 2006;  27 517-524
    Google Scholar
  • 29 Miller C H, Burgoon M, Grandpre J R. et al . Identifying principal risk factors for the initiation of adolescent smoking behaviors: the significance of psychological reactance.  Health Commun. 2006;  19 241-252
    Google Scholar
  • 30 Schumann A, Hapke U, Meyer C. et al . Prevalence, characteristics, associated mental disorders and predictors of DSM-IV nicotine dependence.  Eur Addict Res. 2004;  10 29-34
    Google Scholar
  • 31 Rounsaville B J, Bryant K, Babor T. et al . Cross system agreement for substance use disorders: DSM-III-R, DSM-IV and ICD-10.  Addiction. 1993;  88 337-348
    Google Scholar
  • 32 Watkins S S, Koob G F, Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.  Nicotine Tob Res. 2000;  2 19-37
    Google Scholar
  • 33 Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.  Proc Natl Acad Sci U S A. 1988;  85 5274-5278
    Google Scholar
  • 34 Balfour D J. Neural mechanisms underlying nicotine dependence.  Addiction. 1994;  89 1419-1423
    Google Scholar
  • 35 Dani J A, Heinemann S. Molecular and cellular aspects of nicotine abuse.  Neuron. 1996;  16 905-908
    Google Scholar
  • 36 Corrigall W A, Franklin K B, Coen K M. et al . The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.  Psychopharmacology (Berl). 1992;  107 285-289
    Google Scholar
  • 37 Nelson C B, Wittchen H U. Smoking and nicotine dependence. Results from a sample of 14- to 24-year-olds in Germany.  Eur Addict Res. 1998;  4 42-49
    Google Scholar
  • 38 Centers for Disease Control and Prevention (CDC) . Cigarette smoking among adults - United States, 1995.  MMWR Morb Mortal Wkly Rep. 1997;  46 1217-1220
    Google Scholar
  • 39 West R, Sohal T. “Catastrophic” pathways to smoking cessation: findings from national survey.  Bmj. 2006;  332 458-460
    Google Scholar
  • 40 Hughes J R, Hatsukami D. Signs and symptoms of tobacco withdrawal.  Arch Gen Psychiatry. 1986;  43 289-294
    Google Scholar
  • 41 Le Foll B, Goldberg S R. Nicotine as a typical drug of abuse in experimental animals and humans.  Psychopharmacology (Berl). 2006;  184 367-381
    Google Scholar
  • 42 Malin D H, Lake J R, Carter V A. et al . Naloxone precipitates nicotine abstinence syndrome in the rat.  Psychopharmacology (Berl). 1993;  112 339-342
    Google Scholar
  • 43 Epping-Jordan M P, Watkins S S, Koob G F. et al . Dramatic decreases in brain reward function during nicotine withdrawal.  Nature. 1998;  393 76-79
    Google Scholar
  • 44 Benwell M E, Balfour D J, Anderson J M. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.  J Neurochem. 1988;  50 1243-1247
    Google Scholar
  • 45 Breese C R, Marks M J, Logel J. et al . Effect of smoking history on [3H]nicotine binding in human postmortem brain.  J Pharmacol Exp Ther. 1997;  282 7-13
    Google Scholar
  • 46 Perry D C, Davila-Garcia M I, Stockmeier C A. et al . Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.  J Pharmacol Exp Ther. 1999;  289 1545-1552
    Google Scholar
  • 47 Benwell M E, Balfour D J. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles.  Psychopharmacology (Berl). 1979;  63 7-11
    Google Scholar
  • 48 Benwell M E, Balfour D J. The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain.  Eur J Pharmacol. 1982;  84 71-77
    Google Scholar
  • 49 Fidler J A, Wardle J, Brodersen N H. et al . Vulnerability to smoking after trying a single cigarette can lie dormant for three years or more.  Tob Control. 2006;  15 205-209
    Google Scholar
  • 50 Church D F, Pryor W A. Free-radical chemistry of cigarette smoke and its toxicological implications.  Environ Health Perspect. 1985;  64 111-126
    Google Scholar
  • 51 Church D F, Pryor W A. The oxidative stress placed on the lung by cigarette smoke. In: Crystal RG, West JB (eds). The Lung NY: Raven Press 1991: 1975-1979
    Google Scholar
  • 52 MacNee W, Wiggs B, Belzberg A S. et al . The effect of cigarette smoking on neutrophil kinetics in human lungs.  N Engl J Med. 1989;  321 924-928
    Google Scholar
  • 53 Nadel J A. Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies.  Chest. 2000;  117 386S-389S
    Google Scholar
  • 54 Walsh D E, Greene C M, Carroll T P. et al . Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium.  J Biol Chem. 2001;  276 35 494-35 499
    Google Scholar
  • 55 Shapiro S D. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth.  Thromb Haemost. 1999;  82 846-849
    Google Scholar
  • 56 Arcavi L, Benowitz N L. Cigarette smoking and infection.  Arch Intern Med. 2004;  164 2206-2216
    Google Scholar
  • 57 Dye J A, Adler K B. Effects of cigarette smoke on epithelial cells of the respiratory tract.  Thorax. 1994;  49 825-834
    Google Scholar
  • 58 Marcy T W, Merrill W W. Cigarette smoking and respiratory tract infection.  Clin Chest Med. 1987;  8 381-391
    Google Scholar
  • 59 Kalra R, Singh S P, Savage S M. et al . Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores.  J Pharmacol Exp Ther. 2000;  293 166-171
    Google Scholar
  • 60 Gerrard J W, Heiner D C, Ko C G. et al . Immunoglobulin levels in smokers and non-smokers.  Ann Allergy. 1980;  44 261-262
    Google Scholar
  • 61 U.S. Department of Health and Human Services .The Health Consequences of Smoking: A Report of the Surgeon General.  Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2004
    Google Scholar
  • 62 Lebowitz M D. Smoking habits and changes in smoking habits as they relate to chronic conditions and respiratory symptoms.  Am J Epidemiol. 1977;  105 534-543
    Google Scholar
  • 63 Walraven G E, Nyan O A, Sande M A van der. et al . Asthma, smoking and chronic cough in rural and urban adult communities in The Gambia.  Clin Exp Allergy. 2001;  31 1679-1685
    Google Scholar
  • 64 Troisi R J, Speizer F E, Rosner B. et al . Cigarette smoking and incidence of chronic bronchitis and asthma in women.  Chest. 1995;  108 1557-1561
    Google Scholar
  • 65 Pilotto L S, Smith B J, Nitschke M. et al . Industry, air quality, cigarette smoke and rates of respiratory illness in Port Adelaide.  Aust N Z J Public Health. 1999;  23 657-660
    Google Scholar
  • 66 Tobacco smoking.  IARC Monogr Eval Carcinog Risk Chem Hum. 1986;  38 35-394
    Google Scholar
  • 67 Doll R, Hill A B. The mortality of doctors in relation to their smoking habits; a preliminary report.  Br Med J. 1954;  1 1451-1455
    Google Scholar
  • 68 Bouchardy C, Benhamou S, Jourenkova N. et al . Metabolic genetic polymorphisms and susceptibility to lung cancer.  Lung Cancer. 2001;  32 109-112
    Google Scholar
  • 69 Doll R, Peto R, Boreham J. et al . Mortality in relation to smoking: 50 years' observations on male British doctors.  Bmj. 2004;  328 1519
    Google Scholar
  • 70 Piipari R, Jaakkola J J, Jaakkola N. et al . Smoking and asthma in adults.  Eur Respir J. 2004;  24 734-739
    Google Scholar
  • 71 Senthilselvan A, Chen Y, Dosman J A. Predictors of asthma and wheezing in adults. Grain farming, sex, and smoking.  Am Rev Respir Dis. 1993;  148 667-670
    Google Scholar
  • 72 Godtfredsen N S, Lange P, Prescott E. et al . Changes in smoking habits and risk of asthma: a longitudinal population based study.  Eur Respir J. 2001;  18 549-554
    Google Scholar
  • 73 Eisner M D, Klein J, Hammond S K. et al . Directly measured second hand smoke exposure and asthma health outcomes.  Thorax. 2005;  60 814-821
    Google Scholar
  • 74 Gilliland F D, Islam T, Berhane K. et al . Regular smoking and asthma incidence in adolescents.  Am J Respir Crit Care Med. 2006;  174 1094-1100
    Google Scholar
  • 75 Genuneit J, Weinmayr G, Radon K. et al . Smoking and the incidence of asthma during adolescence: results of a large cohort study in Germany.  Thorax. 2006;  61 572-578
    Google Scholar
  • 76 Piitulainen E, Sveger T. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency.  Acta Paediatr. 1998;  87 1120-1124
    Google Scholar
  • 77 Braman S S. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines.  Chest. 2006;  129 104S-115S
    Google Scholar
  • 78 Andersen A, Berge S R, Engeland A. et al . Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers.  Occup Environ Med. 1996;  53 708-713
    Google Scholar
  • 79 Blake G H, Abell T D, Stanley W G. Cigarette smoking and upper respiratory infection among recruits in basic combat training.  Ann Intern Med. 1988;  109 198-202
    Google Scholar
  • 80 Cohen S, Tyrrell D A, Russell M A. et al . Smoking, alcohol consumption, and susceptibility to the common cold.  Am J Public Health. 1993;  83 1277-1283
    Google Scholar
  • 81 Plaschke P P, Janson C, Norrman E. et al . Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking.  Am J Respir Crit Care Med. 2000;  162 920-924
    Google Scholar
  • 82 Nuorti J P, Butler J C, Farley M M. et al . Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.  N Engl J Med. 2000;  342 681-689
    Google Scholar
  • 83 Almirall J, Gonzalez C A, Balanzo X. et al . Proportion of community-acquired pneumonia cases attributable to tobacco smoking.  Chest. 1999;  116 375-379
    Google Scholar
  • 84 Straus W L, Plouffe J F, File Jr T M. et al . Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group.  Arch Intern Med. 1996;  156 1685-1692
    Google Scholar
  • 85 Kark J D, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men.  N Engl J Med. 1982;  307 1042-1046
    Google Scholar
  • 86 Buskin S E, Gale J L, Weiss N S. et al . Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990.  Am J Public Health. 1994;  84 1750-1756
    Google Scholar
  • 87 Alcaide J, Altet M N, Plans P. et al . Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study.  Tuber Lung Dis. 1996;  77 112-116
    Google Scholar
  • 88 Ryu J H, Colby T V, Hartman T E. et al . Smoking-related interstitial lung diseases: a concise review.  Eur Respir J. 2001;  17 122-132
    Google Scholar
  • 89 Katzenstein A L, Myers J L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.  Am J Respir Crit Care Med. 1998;  157 1301-1315
    Google Scholar
  • 90 Coultas D B, Zumwalt R E, Black W C. et al . The epidemiology of interstitial lung diseases.  Am J Respir Crit Care Med. 1994;  150 967-972
    Google Scholar
  • 91 Johnston I D, Prescott R J, Chalmers J C. et al . British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.  Thorax. 1997;  52 38-44
    Google Scholar
  • 92 Marshall R P, Puddicombe A, Cookson W O. et al . Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.  Thorax. 2000;  55 143-146
    Google Scholar
  • 93 Schwartz D A, Merchant R K, Helmers R A. et al . The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis.  Am Rev Respir Dis. 1991;  144 504-506
    Google Scholar
  • 94 Baumgartner K B, Samet J M, Stidley C A. et al . Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med. 1997;  155 242-248
    Google Scholar
  • 95 Hubbard R, Venn A, Lewis S. et al . Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.  Am J Respir Crit Care Med. 2000;  161 5-8
    Google Scholar
  • 96 Hartman T E, Primack S L, Kang E Y. et al . Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT.  Chest. 1996;  110 378-382
    Google Scholar
  • 97 Yousem S A, Colby T V, Gaensler E A. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia.  Mayo Clin Proc. 1989;  64 1373-1380
    Google Scholar
  • 98 Niewoehner D E, Kleinerman J, Rice D B. Pathologic changes in the peripheral airways of young cigarette smokers.  N Engl J Med. 1974;  291 755-758
    Google Scholar
  • 99 Myers J L, Veal C C F, Shin M S. et al . Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases.  Am Rev Respir Dis. 1987;  135 880-884
    Google Scholar
  • 100 Favara B E, Feller A C, Pauli M. et al . Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.  Med Pediatr Oncol. 1997;  29 157-166
    Google Scholar
  • 101 Hance A J, Basset F, Saumon G. et al . Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis.  Ann N Y Acad Sci. 1986;  465 643-656
    Google Scholar
  • 102 Casolaro M A, Bernaudin J F, Saltini C. et al . Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking.  Am Rev Respir Dis. 1988;  137 406-411
    Google Scholar
  • 103 Westedt M L, Hazes J M, Breedveld F C. et al . Cigarette smoking and pulmonary diffusion defects in rheumatoid arthritis.  Rheumatol Int. 1998;  18 1-4
    Google Scholar
  • 104 Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis.  J Rheumatol. 2000;  27 630-637
    Google Scholar
  • 105 Banks J, Banks C, Cheong B. et al . An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis.  Q J Med. 1992;  85 795-806
    Google Scholar
  • 106 Hyland R H, Gordon D A, Broder I. et al . A systematic controlled study of pulmonary abnormalities in rheumatoid arthritis.  J Rheumatol. 1983;  10 395-405
    Google Scholar
  • 107 Merkel F, Pullig O, Marx M. et al . Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.  Nephrol Dial Transplant. 1994;  9 372-376
    Google Scholar
  • 108 Kelly P T, Haponik E F. Goodpasture syndrome: molecular and clinical advances.  Medicine (Baltimore). 1994;  73 171-185
    Google Scholar
  • 109 Pauwels R A, Rabe K F. Burden and clinical features of chronic obstructive pulmonary disease (COPD).  Lancet. 2004;  364 613-620
    Google Scholar
  • 110 Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990 - 2020: Global Burden of Disease Study.  Lancet. 1997;  349 1498-1504
    Google Scholar
  • 111 Behr J, Nowak D. Tobacco smoke and respiratory disease.  In: d'Amato G, Holgate S (eds). European Respiratory Monograph (7) The impact of air pollution on respiratory health.  ERS. 2002;  21 161-179
    Google Scholar
  • 112 European Commission .Tobacco or Health in the European Union - past, present and future. The ASPECT Consortium. Luxembourg: Office for Official Publications of the European Communities 2004
    Google Scholar
  • 113 Shahab L, Jarvis M J, Britton J R. et al . Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample.  Thorax. 2006;  61 1043-1047
    Google Scholar
  • 114 Criée C P, Novak D. Einsparpotential durch Prävention bei COPD. In: Schauder P, Berthold H, Eckel H, Ollenschläger G (eds). Zukunft sichern: Senkung der Zahl chronisch Kranker, Verwirklichung einer realistischen Utopie. Köln: Deutscher Ärzteverlag 2006: 205-208
    Google Scholar
  • 115 de Marco R, Accordini S, Cerveri I. et al . An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.  Thorax. 2004;  59 120-125
    Google Scholar
  • 116 Chapman K R, Mannino D M, Soriano J B. et al . Epidemiology and costs of chronic obstructive pulmonary disease.  Eur Respir J. 2006;  27 188-207
    Google Scholar
  • 117 Nowak D, Berger K, Lippert B. et al . Epidemiology and health economics of COPD across Europe: a critical analysis.  Treat Respir Med. 2005;  4 381-395
    Google Scholar
  • 118 Buist A S, McBurnie M A, Vollmer W M. et al . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.  Lancet. 2007;  370 741-750
    Google Scholar
  • 119 Burney P. The pharmacoepidemiology of COPD: Recent advances and methodological discussion.  Eur Respir J. 2003;  22 1S-44S
    Google Scholar
  • 120 Lundback B, Lindberg A, Lindstrom M. et al . Not 15 but 50 % of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies.  Respir Med. 2003;  97 115-122
    Google Scholar
  • 121 Wedzicha J A, Donaldson G C. Exacerbations of chronic obstructive pulmonary disease.  Respir Care. 2003;  48 1204-1213; discussion 1213 - 1205
    Google Scholar
  • 122 Lundback B, Gulsvik A, Albers M. et al . Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly.  Eur Respir J Suppl. 2003;  40 3s-9s
    Google Scholar
  • 123 Lokke A, Lange P, Scharling H. et al . Developing COPD: a 25 year follow up study of the general population.  Thorax. 2006;  61 935-939
    Google Scholar
  • 124 Prescott E, Bjerg A M, Andersen P K. et al . Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.  Eur Respir J. 1997;  10 822-827
    Google Scholar
  • 125 Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function.  Eur Respir J. 1994;  7 477-483
    Google Scholar
  • 126 Chapman K R. Chronic obstructive pulmonary disease: are women more susceptible than men?.  Clinics in Chest Medicine. 2004;  25 331-341
    Google Scholar
  • 127 Cookson W O. State of the art. Genetics and genomics of chronic obstructive pulmonary disease.  Proc Am Thorac Soc. 2006;  3 473-475
    Google Scholar
  • 128 Rennard S I, Vestbo J. COPD: the dangerous underestimate of 15 %.  Lancet. 2006;  367 1216-1219
    Google Scholar
  • 129 Falk G A, Briscoe W A. Alpha-1-antitrypsin deficiency in chronic obstructive pulmonary disease.  Ann Intern Med. 1970;  72 427-429
    Google Scholar
  • 130 Wouters E F. Chronic obstructive pulmonary disease. 5: systemic effects of COPD.  Thorax. 2002;  57 1067-1070
    Google Scholar
  • 131 Reid M B. COPD as a muscle disease.  Am J Respir Crit Care Med. 2001;  164 1101-1102
    Google Scholar
  • 132 Anthonisen N R, Skeans M A, Wise R A. et al . The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.  Ann Intern Med. 2005;  142 233-239
    Google Scholar
  • 133 Andreas S, Anker S D, Scanlon P D. et al . Neurohumoral activation as a link to systemic manifestation of chronic lung disease.  Chest. 2005;  128 3618-3624
    Google Scholar
  • 134 Yanbaeva D G, Dentener M A, Creutzberg E C. et al . Systemic Effects of Smoking.  Chest. 2007;  131 1557-1566
    Google Scholar
  • 135 Cerveri I, Accordini S, Corsico A. et al . Chronic cough and phlegm in young adults.  Eur Respir J. 2003;  22 413-417
    Google Scholar
  • 136 Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.  Am J Respir Crit Care Med. 1996;  153 1530-1535
    Google Scholar
  • 137 Kerstjens H A, Rijcken B, Schouten J P. et al . Decline of FEV1 by age and smoking status: facts, figures, and fallacies.  Thorax. 1997;  52 820-827
    Google Scholar
  • 138 Fletcher C, Peto R. The natural history of chronic airflow obstruction.  Br Med J. 1977;  1 1645-1648
    Google Scholar
  • 139 Gold D R, Wang X, Wypij D. et al . Effects of cigarette smoking on lung function in adolescent boys and girls.  N Engl J Med. 1996;  335 931-937
    Google Scholar
  • 140 Sherrill D L, Lebowitz M D, Knudson R J. et al . Smoking and symptom effects on the curves of lung function growth and decline.  Am Rev Respir Dis. 1991;  144 17-22
    Google Scholar
  • 141 Xu X, Weiss S T, Rijcken B. et al . Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences.  Eur Respir J. 1994;  7 1056-1061
    Google Scholar
  • 142 Anthonisen N R. Lung Health Study.  Am Rev Respir Dis. 1989;  140 871-872
    Google Scholar
  • 143 Anthonisen N R, Connett J E, Enright P L. et al . Hospitalizations and mortality in the Lung Health Study.  Am J Respir Crit Care Med. 2002;  166 333-339
    Google Scholar
  • 144 Anthonisen N R, Lindgren P G, Tashkin D P. et al . Bronchodilator response in the lung health study over 11 yrs.  Eur Respir J. 2005;  26 45-51
    Google Scholar
  • 145 Scanlon P D, Connett J E, Waller L A. et al . Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.  Am J Respir Crit Care Med. 2000;  161 381-390
    Google Scholar
  • 146 Viegi G, Paoletti P, Carrozzi L. et al . CO diffusing capacity in a general population sample: relationships with cigarette smoking and airflow obstruction.  Respiration. 1993;  60 155-161
    Google Scholar
  • 147 Viegi G, Sherrill D L, Carrozzi L. et al . An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern italy.  Chest. 2001;  120 74-80
    Google Scholar
  • 148 Verbanck S, Schuermans D, Paiva M. et al . Small airway function improvement after smoking cessation in smokers without airway obstruction.  Am J Respir Crit Care Med. 2006;  174 853-857
    Google Scholar
  • 149 Willemse B W, Postma D S, Timens W. et al . The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation.  Eur Respir J. 2004;  23 464-476
    Google Scholar
  • 150 Willemse B W, ten Hacken N H, Rutgers B. et al . Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD.  Eur Respir J. 2004;  24 391-396
    Google Scholar
  • 151 Magnussen H, Goeckenjan G, Kohler D. et al . Guidelines to long-term oxygen therapy.  Pneumologie. 2001;  55 454-464
    Google Scholar
  • 152 Lacasse Y, LaForge J, Maltais F. Got a match? Home oxygen therapy in current smokers.  Thorax. 2006;  61 374-375
    Google Scholar
  • 153 Heidrich J, Wellmann J, Heuschmann P U. et al . Mortality and morbidity from coronary heart disease attributable to passive smoking.  Eur Heart J. 2007;  28 2498-2502
    Google Scholar
  • 154 European Respiratory Society .Lifting the smokescreen.  Brussels: European Respiratory Society 2006
    Google Scholar
  • 155 Jaakkola M S, Jaakkola J J. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention.  Eur Respir J. 2006;  28 397-408
    Google Scholar
  • 156 Lam T H, Ho L M, Hedley A J. et al . Secondhand smoke and respiratory ill health in current smokers.  Tob Control. 2005;  14 307-314
    Google Scholar
  • 157 Raupach T, Radon K, Nowak D. et al . Passive Smoking - Health Consequences and Effects of Exposure Prevention.  Pneumologie. 2008;  62 44-50
    Google Scholar
  • 158 Jimenez-Ruiz C A, Masa F, Miravitlles M. et al . Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD.  Chest. 2001;  119 1365-1370
    Google Scholar
  • 159 Jimenez-Ruiz C, Miravitlles M, Sobradillo V. et al . Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?.  Nicotine Tob Res. 2004;  6 649-653
    Google Scholar
  • 160 Hertzen L von, Reunanen A, Impivaara O. et al . Airway obstruction in relation to symptoms in chronic respiratory disease - a nationally representative population study.  Respiratory Medicine. 2000;  94 356-363
    Google Scholar
  • 161 Medici T C, Unger S, Ruegger M. Smoking pattern of smokers with and without tobacco-smoke-related lung diseases.  Am Rev Respir Dis. 1985;  131 385-388
    Google Scholar
  • 162 Killen J, Fortmann S, Kraemer H. et al . Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation.  J Consult Clin Psychol. 1992;  60 797-801
    Google Scholar
  • 163 Clark K D, Wardrobe-Wong N, Elliott J J. et al . Cigarette smoke inhalation and lung damage in smoking volunteers.  Eur Respir J. 1998;  12 395-399
    Google Scholar
  • 164 Wagena E J, Huibers M J, Schayck C P van. Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.  Thorax. 2001;  56 587-588
    Google Scholar
  • 165 Manen J G van, Bindels P JE, Dekker F W. et al . Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.  Thorax. 2002;  57 412-416
    Google Scholar
  • 166 Wagena E J, Meer R M van der, Ostelo R J. et al . The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review.  Respir Med. 2004;  98 805-815
    Google Scholar
  • 167 Yohannes A M, Roomi J, Baldwin R C. et al . Depression in elderly outpatients with disabling chronic obstructive pulmonary disease.  Age and Ageing. 1998;  27 155-160
    Google Scholar
  • 168 Dudley D, Glaser E, Jorgenson B. et al . Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease. 3. Dealing with psychiatric disease (as distinguished from psychosocial or psychophysiologic problems).  Chest. 1980;  77 667
    Google Scholar
  • 169 Isoaho R, Puolijoki H, Huhti E. et al . Chronic obstructive pulmonary disease and self-maintaining functions in the elderly - a population-based study.  Scand J Prim Health Care. 1995;  13 122-127
    Google Scholar
  • 170 O'Neill E. Illness representations and coping of women with chronic obstructive pulmonary disease: a pilot study.  Heart Lung. 2002;  31 295-302
    Google Scholar
  • 171 DiMarco F, Verga M, Reggente M. et al . Anxiety and depression in COPD patients: The roles of gender and disease severity.  Respir Med. 2006;  100 1767-1774
    Google Scholar
  • 172 Ng T P, Niti M, Tan W C. et al . Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.  Arch Intern Med. 2007;  167 60-67
    Google Scholar
  • 173 Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004: CD000031
    Google Scholar
  • 174 Breslau N, Johnson E O, Hiripi E. et al . Nicotine Dependence in the United States - Prevalence, Trends, and Smoking Persistence.  Arch Gen Psychiatry. 2001;  58 810-816
    Google Scholar
  • 175 Glassman A H, Covey L S, Stetner F. et al . Smoking cessation and the course of major depression: a follow-up study.  Lancet. 2001;  357 1929-1932
    Google Scholar
  • 176 Breslau N, Peterson E L, Schultz L R. et al . Major Depression and Stages of Smoking.  A Longitudinal Investigation. 1998;  55 161-166
    Google Scholar
  • 177 Dierker L, Avenevoli S, Stolar M. et al . Smoking and depression: an examination of mechanisms of comorbidity.  Am J Psychiatry. 2002;  159 947-953
    Google Scholar
  • 178 Covey L, Glassman A, Stetner F. Cigarette smoking and major depression.  J Addict Dis. 1998;  17 35-46
    Google Scholar
  • 179 Wilhelm K, Arnold K, Niven H. et al . Grey lungs and blue moods: smoking cessation in the context of lifetime depression history.  Aust N Z J Psychiatry. 2004;  38 896-905
    Google Scholar
  • 180 Breslau N. Psychiatric comorbidity of smoking and nicotine dependence.  Behav Genet. 1995;  25 95-101
    Google Scholar
  • 181 John U, Meyer C, Rumpf H J. et al . Smoking, nicotine dependence and psychiatric comorbidity - a population-based study including smoking cessation after three years.  Drug Alcohol Depend. 2004;  76 287-295
    Google Scholar
  • 182 Haug N A, Heinberg L J, Guarda A S. Cigarette smoking and its relationship to other substance use among eating disordered inpatients.  Eat Weight Disord. 2001;  6 130-139
    Google Scholar
  • 183 Kordon A, Kahl K G. Attention-deficit/hyperactivity disorder (ADHS) in adulthood.  Psychother Psychosom Med Psychol. 2004;  54 124-136
    Google Scholar
  • 184 Anthonisen N R, Connett J E, Murray R P. Smoking and lung function of Lung Health Study participants after 11 years.  Am J Respir Crit Care Med. 2002;  166 675-679
    Google Scholar
  • 185 Heatherton T F, Kozlowski L T, Frecker R C. et al . The Fagerstrom-Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire.  Br J Addict. 1991;  86 1119-1127
    Google Scholar
  • 186 Anda R F, Williamson D F, Escobedo L G. et al . Depression and the dynamics of smoking. A national perspective.  Jama. 1990;  264 1541-1545
    Google Scholar
  • 187 Killen J D, Fortmann S P, Kraemer H C. et al . Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.  J Consult Clin Psychol. 1996;  64 1060-1067
    Google Scholar
  • 188 Herrmann C, Buss U. Vorstellung und Validierung einer deutschen Version der „Hospital Anxiety and Depression Scale” (HAD-Skala); ein Fragebogen zur Erfassung des psychischen Befindens bei Patienten mit körperlichen Beschwerden.  Diagnostica. 1994;  40 143-154
    Google Scholar
  • 189 Löwe B. PHQ-D - Gesundheitsfragebogen für Patienten. In: Schumacher J, Strauss B (eds). Klinische Interviews und Ratingskalen Göttingen: Hogrefe 2004: 321-327
    Google Scholar
  • 190 Riemann K, Gerber U. Standardisierung von Fragestellungen zum Rauchen: ein Beitrag zur Qualitätssicherung in der Präventionsforschung. 4 ed: BZgA. Köln: Bundeszentrale für gesundheitliche Aufklärung 2000
    Google Scholar
  • 191 Hilberink S R, Jacobs J E, Schlosser M. et al . Characteristics of patients with COPD in three motivational stages related to smoking cessation.  Patient Educ Couns. 2006;  61 449-457
    Google Scholar
  • 192 Bize R, Burnand B, Mueller Y. et al .Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2005: CD004705
    Google Scholar
  • 193 West R, Hajek P, Stead L. et al . Outcome criteria in smoking cessation trials: proposal for a common standard.  Addiction. 2005;  100 299-303
    Google Scholar
  • 194 Brandt C J, Ellegaard H, Joensen M. et al . Effect of diagnosis of “smoker's lung”. RYLUNG Group.  Lancet. 1997;  349 253
    Google Scholar
  • 195 Humerfelt S, Eide G E, Kvåle G. et al . Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure.  Eur Respir J. 1998;  11 284-290
    Google Scholar
  • 196 Walters N, Coleman T. Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not.  Br J Gen Pract. 2002;  52 132-134
    Google Scholar
  • 197 Bednarek M, Gorecka D, Wielgomas J. et al . Smokers with airway obstruction are more likely to quit smoking.  Thorax. 2006;  61 869-73
    Google Scholar
  • 198 Gorecka D, Bednarek M, Nowinski A. et al . Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate.  Chest. 2003;  123 1916-1923
    Google Scholar
  • 199 Townsend C O, Clark M M, Jett J R. et al . Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening.  Cancer. 2005;  103 2154-2162
    Google Scholar
  • 200 A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report.  Jama. 2000;  283 3244-3254
    Google Scholar
  • 201 Soria R, Legido A, Escolano C. et al . A randomised controlled trial of motivational interviewing for smoking cessation.  Br J Gen Pract. 2006;  56 768-774
    Google Scholar
  • 202 Miller W R. Motivational interviewing: research, practice, and puzzles.  Addict Behav. 1996;  21 835-842
    Google Scholar
  • 203 O'Hara P, Grill J, Rigdon M A. et al . Design and results of the initial intervention program for the Lung Health Study. The Lung Health Study Research Group.  Prev Med. 1993;  22 304-315
    Google Scholar
  • 204 Anthonisen N R, Connett J E, Kiley J P. et al . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.  Jama. 1994;  272 1497-1505
    Google Scholar
  • 205 Godtfredsen N S, Vestbo J, Osler M. et al . Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study.  Thorax. 2002;  57 967-972
    Google Scholar
  • 206 Kanner R E, Anthonisen N R, Connett J E. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.  Am J Respir Crit Care Med. 2001;  164 358-364
    Google Scholar
  • 207 Jo Y H, Talmage D A, Role L W. Nicotinic receptor-mediated effects on appetite and food intake.  J Neurobiol. 2002;  53 618-632
    Google Scholar
  • 208 Williamson D F, Madans J, Anda R F. et al . Smoking cessation and severity of weight gain in a national cohort.  N Engl J Med. 1991;  324 739-745
    Google Scholar
  • 209 Flegal K M, Troiano R P, Pamuk E R. et al . The influence of smoking cessation on the prevalence of overweight in the United States.  N Engl J Med. 1995;  333 1165-1170
    Google Scholar
  • 210 Carroll M E, Meisch R A. Increased drug-reinforced behaviour due to food deprivation. In: Thompson T, Dews PB, JE B (eds). Advances in Behavioural Pharmacology. Orlando: Academic Press Inc 1984: 47-88
    Google Scholar
  • 211 Swan G E, Carmelli D. Characteristics associated with excessive weight gain after smoking cessation in men.  Am J Public Health. 1995;  85 73-77
    Google Scholar
  • 212 Pomerleau C S, Zucker A N, Stewart A J. Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers.  Nicotine Tob Res. 2001;  3 51-60
    Google Scholar
  • 213 Hughes J R, Gust S W, Skoog K. et al . Symptoms of tobacco withdrawal. A replication and extension.  Arch Gen Psychiatry. 1991;  48 52-59
    Google Scholar
  • 214 Pisinger C, Jorgensen T. Weight concerns and smoking in a general population: the Inter99 study.  Prev Med. 2007;  44 283-289
    Google Scholar
  • 215 Nordstrom B L, Kinnunen T, Utman C H. et al . Long-term effects of nicotine gum on weight gain after smoking cessation.  Nicotine Tob Res. 1999;  1 259-268
    Google Scholar
  • 216 Hays J T, Hurt R D, Rigotti N A. et al . Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.  Ann Intern Med. 2001;  135 423-433
    Google Scholar
  • 217 Marcus B H, Albrecht A E, King T K. et al . The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial.  Arch Intern Med. 1999;  159 1229-1234
    Google Scholar
  • 218 Kadowaki T, Watanabe M, Okayama A. et al . Continuation of smoking cessation and following weight change after intervention in a healthy population with high smoking prevalence.  J Occup Health. 2006;  48 402-406
    Google Scholar
  • 219 Lange P, Groth S, Nyboe G J. et al . Effects of smoking and changes in smoking habits on the decline of FEV1.  Eur Respir J. 1989;  2 811-816
    Google Scholar
  • 220 Simmons M S, Connett J E, Nides M A. et al . Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study.  Eur Respir J. 2005;  25 1011-1017
    Google Scholar
  • 221 Sherrill D L, Enright P, Cline M. et al . Rates of decline in lung function among subjects who restart cigarette smoking.  Chest. 1996;  109 1001-1005
    Google Scholar
  • 222 Bolliger C T, Zellweger J P, Danielsson T. et al . Influence of long-term smoking reduction on health risk markers and quality of life.  Nicotine Tob Res. 2002;  4 433-439
    Google Scholar
  • 223 Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption.  Tobacco Control. 2006;  15 472-480
    Google Scholar
  • 224 Raupach T, Shahab L, Neubert K. et al .Implementing a hospital-based smoking cessation programme: Evidence for a learning effect. Patient Educ Couns 2008 (in press)
    Google Scholar
  • 225 Wagena E J, Zeegers M P, Schayck C P van. et al . Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.  Drug Saf. 2003;  26 381-403
    Google Scholar
  • 226 van der Meer R M, Wagena E J, Ostelo R W. et al .Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003: CD002999
    Google Scholar
  • 227 Tashkin D, Kanner R, Bailey W. et al . Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.  Lancet. 2001;  357 1571-1575
    Google Scholar
  • 228 Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.  Chest. 2006;  130 334-342
    Google Scholar
  • 229 Wagena E J, Knipschild P G, Huibers M JH. et al . Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease.  Arch Intern Med. 2005;  165 2286-2292
    Google Scholar
  • 230 Hering T, Bölcskei P, Storz C. et al .Strukturierte Raucherberatung und Tabakentwöhnung - Tabakentwöhnung in der Praxis-Sprechstunde (das Tabakentwöhnungskonzept des Bundesverbandes der Pneumologen in Deutschland - BDP). In: Vorträge der 5 Deutschen Nikotin Konferenz: ed. K. Haustein. Erfurt: Deutsche Gesellschaft für Nikotinforschung 2002: 121-124
    Google Scholar
  • 231 Moher M, Hey K, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database Syst Rev 2005: CD003440
    Google Scholar
  • 232 Twardella D, Brenner H. Effects of practitioner education, practitioner payment and reimbursement of patients' drug costs on smoking cessation in primary care: a cluster randomised trial.  Tobacco Control. 2007;  16 15-21
    Google Scholar
  • 233 Silagy C, Lancaster T, Stead L. et al .Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004: CD000146
    Google Scholar
  • 234 Organization WH .Regulation of Nicotine Replacement Therapies: An Expert Consensus. Copenhagen: Regional Office for Europe 2001
    Google Scholar
  • 235 Gonzales D, Rennard S I, Nides M. et al . Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.  Jama. 2006;  296 47-55
    Google Scholar
  • 236 Nides M, Oncken C, Gonzales D. et al . Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.  Arch Intern Med. 2006;  166 1561-1568
    Google Scholar
  • 237 Oncken C, Gonzales D, Nides M. et al . Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.  Arch Intern Med. 2006;  166 1571-1577
    Google Scholar
  • 238 Tonstad S, Tonnesen P, Hajek P. et al . Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.  Jama. 2006;  296 64-71
    Google Scholar
  • 239 Jorenby D E, Hays J T, Rigotti N A. et al . Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.  Jama. 2006;  296 56-63
    Google Scholar
  • 240 Cahill K, Stead L F, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007: CD006103
    Google Scholar
  • 241 Gourlay S G, Stead L F, Benowitz N L. Clonidine for smoking cessation. Cochrane Database Syst Rev 2004: CD000058
    Google Scholar
  • 242 Bundeszentrale für gesundheitliche Aufklärung (BzgA) .Kriterien guter Praxis in der Gesundheitsförderung bei sozial Benachteiligten. Köln 2005
    Google Scholar
  • 243 Morgan W J. Maternal smoking and infant lung function. Further evidence for an in utero effect.  Am J Respir Crit Care Med. 1998;  158 689-690
    Google Scholar
  • 244 Ruff L K, Volmer T, Nowak D. et al . The economic impact of smoking in Germany.  Eur Respir J. 2000;  16 385-390
    Google Scholar
  • 245 Parrott S, Godfrey C, Raw M. Costs of employee smoking in the workplace in Scotland.  Tob Control. 2000;  9 187-192
    Google Scholar
  • 246 Murray R P, Connett J E, Rand C S. et al . Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years.  Prev Med. 2002;  35 314-319
    Google Scholar
  • 247 Raupach T, Shahab L, Neubert K. et al . Implementing a hospital-based smoking cessation programme: Evidence for a learning effect.  Patient Educ Couns. 2008;  70 199-204
    Google Scholar
  • 248 Tengs T O, Adams M E, Pliskin J S. et al . Five-hundred life-saving interventions and their cost-effectiveness.  Risk Anal. 1995;  15 369-390
    Google Scholar
  • 249 Thomas R, Perera R. School-based programmes for preventing smoking.  Cochrane Database Syst Rev. 2006;  3 CD001293
    Google Scholar
  • 250 Secker-Walker R H, Gnich W, Platt S. et al .Community interventions for reducing smoking among adults. Cochrane Database Syst Rev 2002: CD001745
    Google Scholar
  • 251 Stead L F, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005: CD001007
    Google Scholar

Prof. Dr. Stefan Andreas

Lungenfachklinik Immenhausen

Robert Koch-Straße 3

34376 Immenhausen

Email: sandreas@lungenfachklinik-immenhausen.de